Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase

Eur J Pharmacol. 1977 Nov 15;46(2):177-80. doi: 10.1016/0014-2999(77)90254-0.

Abstract

The effects were examined of two inhibitors of GABA-aminotransferase, amino-oxyacetic acid (AOAA) and RMI-71645-16, on depolarization-induced (30 mM K+) dopamine (DA) release from rat striatal slices. When added to the medium, these drugs increased the release of radiolabeled DA, either accumulated by high-affinity uptake or synthesized from 14C-tyrosine. AOAA did not modify the release of 14C-acetylcholine from striatal slices or 3H-noradrenaline from cortical slices. Moreover, 3H-DA release from substantia nigra was not affected. The data suggest the possibility that the effects of GABA-T inhibitors on striatal DA release are mediated by intrinsic GABA-ergic neurons.

MeSH terms

  • 4-Aminobutyrate Transaminase / antagonists & inhibitors*
  • Aminooxyacetic Acid / pharmacology
  • Animals
  • Corpus Striatum / drug effects
  • Corpus Striatum / metabolism*
  • Dopamine / metabolism*
  • In Vitro Techniques
  • Male
  • Rats
  • Substantia Nigra / metabolism
  • Transaminases / antagonists & inhibitors*
  • gamma-Aminobutyric Acid / pharmacology

Substances

  • Aminooxyacetic Acid
  • gamma-Aminobutyric Acid
  • Transaminases
  • 4-Aminobutyrate Transaminase
  • Dopamine